Artelo Biosciences, Inc. (ARTL) vs INVO Fertility, Inc. (IVF)

A side-by-side comparison of Artelo Biosciences, Inc. and INVO Fertility, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ARTL vs IVF

growth of $100 · dividends reinvested · last 7y
ARTL -99.9% (-63.1%/yr)IVF -100.0% (-81.7%/yr)ARTL compounded faster over this window
Log scale — wide-divergence pair
00001101001kStart $100202120232025$0$0
ARTL IVF

ARTL vs IVF: by the numbers

  • •IVF is the larger company ($1M vs $1M market cap).
  • •Both run net losses; ARTL's is the smaller (0.00% vs -70.18% net margin).

Metrics side by side

Valuation

MetricARTLIVF
P/S ratioN/A0.20
P/B ratio0.280.09

Profitability

MetricARTLIVF
Gross margin0.00%33.34%
Operating margin0.00%-78.72%
Net margin0.00%-70.18%
ROE-253.57%-32.05%
ROIC-219.36%-28.43%

Growth (annualized)

MetricARTLIVF
Revenue CAGR (5Y)N/A39.51%
Total return CAGR (5Y)-64.27%-90.41%

Frequently asked

How have ARTL and IVF total returns compared?
Over the past 5 years, ARTL delivered -64.27% and IVF delivered -90.41% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.